CN Stock MarketDetailed Quotes

300753 Jiangsu Apon Medical Technology

Watchlist
  • 19.36
  • +0.90+4.88%
Trading Dec 25 14:28 CST
2.44BMarket Cap460.95P/E (TTM)

Jiangsu Apon Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-40.00%66.59M
-12.76%103.87M
10.21%47.94M
-19.40%200.9M
-28.54%110.98M
-34.33%119.07M
-73.37%43.5M
-9.25%249.25M
-23.66%155.29M
-18.05%181.31M
Transactional financial assets
47.62%93M
47.62%93M
-26.77%93M
--1M
--63M
--63M
--127M
----
----
----
Notes receivable and accounts receivable
3.86%162.07M
9.48%140.75M
23.13%164.95M
34.36%151.03M
4.11%156.06M
-3.33%128.57M
0.97%133.97M
-8.22%112.41M
11.49%149.9M
11.02%133M
-Notes receivable
-82.27%3.28M
-72.72%3.09M
-79.17%2.48M
66.81%2.63M
63.18%18.52M
778.97%11.35M
51.63%11.9M
-1.31%1.57M
-25.52%11.35M
-93.78%1.29M
-Accounts receivable
15.45%158.79M
17.43%137.66M
33.09%162.47M
33.90%148.4M
-0.73%137.54M
-11.00%117.22M
-2.21%122.07M
-8.31%110.83M
16.22%138.55M
32.97%131.71M
Other receivables (including interest and dividends)
-32.96%7.14M
-8.32%7.83M
-6.02%9.39M
83.67%9.35M
-36.25%10.65M
-51.16%8.54M
-33.41%9.99M
-25.08%5.09M
8.86%16.7M
28.45%17.49M
-Other receivable
----
-8.32%7.83M
----
----
----
-51.16%8.54M
----
-25.08%5.09M
----
28.45%17.49M
Contractual assets
-35.45%1.83M
-24.68%2.14M
-22.59%2.67M
-22.59%2.67M
--2.84M
--2.84M
108.56%3.45M
108.56%3.45M
----
----
Advance payment
-20.29%15.18M
17.05%11.43M
211.78%28.3M
32.64%12.95M
74.54%19.04M
-40.13%9.77M
-39.11%9.08M
18.43%9.76M
-20.86%10.91M
11.00%16.32M
Inventories
30.69%80.22M
7.70%69.24M
-13.23%59.06M
-8.77%55.69M
2.04%61.38M
-7.99%64.29M
-1.26%68.06M
-9.47%61.04M
-0.06%60.16M
53.55%69.87M
Receivable financing
--1.09M
----
--20.02M
--4M
----
----
----
----
----
----
Assets held for sale
----
----
0.00%2.85M
0.00%2.85M
--2.85M
--2.85M
--2.85M
--2.85M
----
----
Other current assets
293.14%7.82M
32.01%3.56M
-30.20%1.96M
22.27%1.87M
-95.22%1.99M
-93.32%2.7M
-94.45%2.81M
-48.24%1.53M
-11.87%41.63M
-2.04%40.42M
Total current assets
1.44%434.95M
7.52%431.83M
7.35%430.14M
-0.69%442.3M
-1.33%428.79M
-12.39%401.62M
-10.39%400.71M
-8.02%445.38M
-8.40%434.59M
0.50%458.4M
Non Current assets
Other equity investment
35.71%28.5M
-8.06%28.5M
-8.06%28.5M
-8.06%28.5M
-32.26%21M
0.00%31M
0.00%31M
0.00%31M
0.00%31M
0.00%31M
Long-term equity investment
9.41%52.15M
-2.89%48.39M
-2.58%48.63M
-6.16%47.04M
-4.84%47.67M
-1.38%49.83M
-1.57%49.92M
3.60%50.13M
21.25%50.09M
21.13%50.53M
Fixed assets
----
21.60%156.56M
----
----
----
-17.22%128.74M
----
30.28%133.3M
----
126.73%155.53M
Constru in process
----
-57.52%19.86M
----
----
----
146.79%46.75M
----
-46.89%37.44M
----
-82.61%18.94M
Intangible assets
7.00%36.98M
-5.78%33.06M
-4.01%33.49M
-4.36%34.03M
-2.67%34.56M
-2.84%35.09M
-1.18%34.89M
7.02%35.58M
3.58%35.5M
1.73%36.12M
Goodwill
0.00%53.24M
0.00%53.24M
0.00%53.24M
0.00%53.24M
-23.29%53.24M
-23.29%53.24M
-23.29%53.24M
-23.29%53.24M
0.00%69.41M
0.00%69.41M
Long deferred expense
-29.56%13.96M
-21.77%16.42M
-18.94%17.67M
-17.65%18.71M
174.09%19.81M
177.68%20.99M
174.12%21.8M
197.64%22.72M
-11.02%7.23M
256.92%7.56M
Deferred tax assets
-35.99%15.93M
-26.67%17.15M
-7.40%22.13M
-8.52%22.79M
109.44%24.89M
110.01%23.39M
137.13%23.9M
185.35%24.91M
80.25%11.88M
170.94%11.14M
Usufruct assets
-7.92%30.21M
-8.27%30.87M
-10.81%31.03M
-10.10%32.59M
-13.20%32.81M
-9.84%33.65M
-11.16%34.79M
-9.28%36.25M
-7.43%37.79M
690.49%37.33M
Other non current assets
----
----
----
-81.46%144.85K
-94.47%113.45K
-59.16%630.6K
-85.17%301.6K
-78.84%781.42K
134.20%2.05M
7.12%1.54M
Total non current assets
-0.77%405.65M
-4.55%404.06M
-2.79%413.54M
-1.90%417.27M
-3.38%408.79M
1.01%423.33M
0.61%425.42M
2.53%425.34M
4.33%423.1M
14.03%419.09M
Total assets
0.36%840.59M
1.33%835.89M
2.12%843.68M
-1.28%859.57M
-2.34%837.58M
-5.99%824.95M
-5.05%826.13M
-3.15%870.72M
-2.53%857.69M
6.54%877.49M
Liabilities
Current liabilities
Short term loan
23.47%48.4M
25.51%49.2M
68.05%49.24M
33.31%39.24M
33.33%39.2M
101.03%39.2M
193.00%29.3M
--29.43M
--29.4M
--19.5M
Notes payable and accounts payable
-39.75%17.08M
8.29%20.77M
-2.63%23.67M
-36.25%29.92M
62.74%28.35M
-4.75%19.18M
43.14%24.31M
69.02%46.93M
-41.34%17.42M
-15.74%20.13M
-Notes payable
----
0.00%1M
--2M
-41.18%1M
-75.00%1M
-56.52%1M
----
-15.00%1.7M
--4M
--2.3M
-Accounts payable
-37.55%17.08M
8.75%19.77M
-10.86%21.67M
-36.06%28.92M
103.80%27.35M
1.93%18.18M
73.85%24.31M
75.55%45.23M
-54.81%13.42M
-25.37%17.83M
Contract liabilities
219.76%23.27M
-17.15%12.83M
-28.00%15.94M
-47.81%16.03M
-3.51%7.28M
85.28%15.49M
219.90%22.14M
582.11%30.71M
73.69%7.54M
122.18%8.36M
Salaries payable
9.25%6.22M
-1.98%5.79M
-13.87%5.96M
4.62%20.85M
-10.69%5.69M
-7.26%5.91M
9.61%6.92M
-22.74%19.93M
-5.10%6.37M
-14.27%6.37M
Taxs payable
5.94%5.6M
138.76%5.86M
27.79%7.05M
51.86%10.04M
-16.31%5.29M
-74.14%2.46M
-24.63%5.51M
-22.16%6.61M
-34.19%6.32M
-22.25%9.5M
Other payable (including interest and dividends)
-72.63%4.46M
-53.51%5.93M
-35.14%5.88M
3.77%7.74M
174.13%16.31M
125.53%12.75M
70.85%9.07M
-21.55%7.46M
10.40%5.95M
-37.11%5.65M
-Other payable
----
-53.51%5.93M
----
----
----
125.53%12.75M
----
-21.55%7.46M
----
-37.11%5.65M
Non current liabilities due within one year
0.21%5.12M
-2.53%4.88M
-16.62%3.84M
25.22%5.52M
--5.11M
--5.01M
--4.6M
--4.41M
----
----
Other current liabilities
166.85%1.6M
-8.42%602.9K
-35.32%510.39K
-66.90%545.55K
-22.82%599.58K
-23.10%658.3K
-10.28%789.06K
227.96%1.65M
57.87%776.86K
89.38%856.01K
Total current liabilities
3.64%111.75M
5.19%105.87M
9.20%112.09M
-11.72%129.87M
46.14%107.82M
43.03%100.65M
91.06%102.65M
92.17%147.12M
31.20%73.78M
24.01%70.37M
Current liabilities
Deferred tax liabilities
-79.68%50.75K
-82.17%48.53K
-86.13%40.67K
-90.17%41.61K
114.75%249.68K
122.23%272.16K
127.63%293.15K
213.33%423.32K
-17.86%116.27K
-17.24%122.47K
Long term deferred income
-5.47%1.73M
-5.39%1.75M
-5.32%1.78M
-5.25%1.8M
-5.18%1.83M
-5.12%1.85M
-5.05%1.88M
-4.30%1.9M
-20.41%1.93M
-2.30%1.95M
Lease liabilities
-7.28%29.6M
-7.30%30.33M
-6.93%31.36M
-11.21%30.66M
-22.43%31.93M
-19.47%32.72M
-16.81%33.69M
-13.36%34.53M
2.95%41.16M
801.74%40.64M
Total non current liabilities
-7.71%31.38M
-7.78%32.14M
-7.49%33.18M
-11.81%32.5M
-21.29%34.01M
-18.41%34.85M
-15.83%35.87M
-12.20%36.86M
1.55%43.21M
541.87%42.71M
Total liabilities
0.92%143.13M
1.85%138M
4.88%145.27M
-11.74%162.38M
21.24%141.82M
19.82%135.5M
43.78%138.51M
55.20%183.98M
18.43%116.98M
78.37%113.08M
Shareholders equity
Paid-in capital
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
0.00%126.05M
Capital reserve funds
0.00%329.91M
0.00%329.91M
0.00%329.91M
0.00%329.91M
-8.74%329.91M
-7.56%329.91M
-6.33%329.91M
-5.08%329.91M
2.43%361.52M
4.02%356.87M
Surplus reserve funds
4.23%43.28M
4.23%43.28M
4.23%43.28M
4.18%43.28M
0.00%41.52M
0.00%41.52M
0.00%41.52M
0.05%41.55M
13.81%41.52M
13.81%41.52M
Retained profit
-2.19%192.58M
3.56%197.67M
4.76%198.33M
4.53%196.97M
-7.23%196.9M
-20.50%190.87M
-25.32%189.32M
-28.76%188.43M
-19.61%212.25M
-5.01%240.09M
Shareholders equity without minority interests
-0.37%691.82M
1.24%696.9M
1.57%697.56M
1.50%696.2M
-6.33%694.38M
-9.97%688.35M
-11.18%686.8M
-12.02%685.93M
-4.90%741.34M
0.81%764.53M
Minority interests
309.39%5.65M
-10.65%986.45K
4.44%852.7K
21.07%992.34K
317.83%1.38M
1,001.83%1.1M
89.95%816.46K
-9.18%819.64K
-137.84%-633.24K
-106.46%-122.42K
Total shareholder equity
0.25%697.46M
1.22%697.89M
1.57%698.41M
1.52%697.2M
-6.07%695.76M
-9.81%689.45M
-11.13%687.61M
-12.01%686.75M
-5.18%740.71M
0.55%764.41M
Total liabilityies and equity
0.36%840.59M
1.33%835.89M
2.12%843.68M
-1.28%859.57M
-2.34%837.58M
-5.99%824.95M
-5.05%826.13M
-3.15%870.72M
-2.53%857.69M
6.54%877.49M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -40.00%66.59M-12.76%103.87M10.21%47.94M-19.40%200.9M-28.54%110.98M-34.33%119.07M-73.37%43.5M-9.25%249.25M-23.66%155.29M-18.05%181.31M
Transactional financial assets 47.62%93M47.62%93M-26.77%93M--1M--63M--63M--127M------------
Notes receivable and accounts receivable 3.86%162.07M9.48%140.75M23.13%164.95M34.36%151.03M4.11%156.06M-3.33%128.57M0.97%133.97M-8.22%112.41M11.49%149.9M11.02%133M
-Notes receivable -82.27%3.28M-72.72%3.09M-79.17%2.48M66.81%2.63M63.18%18.52M778.97%11.35M51.63%11.9M-1.31%1.57M-25.52%11.35M-93.78%1.29M
-Accounts receivable 15.45%158.79M17.43%137.66M33.09%162.47M33.90%148.4M-0.73%137.54M-11.00%117.22M-2.21%122.07M-8.31%110.83M16.22%138.55M32.97%131.71M
Other receivables (including interest and dividends) -32.96%7.14M-8.32%7.83M-6.02%9.39M83.67%9.35M-36.25%10.65M-51.16%8.54M-33.41%9.99M-25.08%5.09M8.86%16.7M28.45%17.49M
-Other receivable -----8.32%7.83M-------------51.16%8.54M-----25.08%5.09M----28.45%17.49M
Contractual assets -35.45%1.83M-24.68%2.14M-22.59%2.67M-22.59%2.67M--2.84M--2.84M108.56%3.45M108.56%3.45M--------
Advance payment -20.29%15.18M17.05%11.43M211.78%28.3M32.64%12.95M74.54%19.04M-40.13%9.77M-39.11%9.08M18.43%9.76M-20.86%10.91M11.00%16.32M
Inventories 30.69%80.22M7.70%69.24M-13.23%59.06M-8.77%55.69M2.04%61.38M-7.99%64.29M-1.26%68.06M-9.47%61.04M-0.06%60.16M53.55%69.87M
Receivable financing --1.09M------20.02M--4M------------------------
Assets held for sale --------0.00%2.85M0.00%2.85M--2.85M--2.85M--2.85M--2.85M--------
Other current assets 293.14%7.82M32.01%3.56M-30.20%1.96M22.27%1.87M-95.22%1.99M-93.32%2.7M-94.45%2.81M-48.24%1.53M-11.87%41.63M-2.04%40.42M
Total current assets 1.44%434.95M7.52%431.83M7.35%430.14M-0.69%442.3M-1.33%428.79M-12.39%401.62M-10.39%400.71M-8.02%445.38M-8.40%434.59M0.50%458.4M
Non Current assets
Other equity investment 35.71%28.5M-8.06%28.5M-8.06%28.5M-8.06%28.5M-32.26%21M0.00%31M0.00%31M0.00%31M0.00%31M0.00%31M
Long-term equity investment 9.41%52.15M-2.89%48.39M-2.58%48.63M-6.16%47.04M-4.84%47.67M-1.38%49.83M-1.57%49.92M3.60%50.13M21.25%50.09M21.13%50.53M
Fixed assets ----21.60%156.56M-------------17.22%128.74M----30.28%133.3M----126.73%155.53M
Constru in process -----57.52%19.86M------------146.79%46.75M-----46.89%37.44M-----82.61%18.94M
Intangible assets 7.00%36.98M-5.78%33.06M-4.01%33.49M-4.36%34.03M-2.67%34.56M-2.84%35.09M-1.18%34.89M7.02%35.58M3.58%35.5M1.73%36.12M
Goodwill 0.00%53.24M0.00%53.24M0.00%53.24M0.00%53.24M-23.29%53.24M-23.29%53.24M-23.29%53.24M-23.29%53.24M0.00%69.41M0.00%69.41M
Long deferred expense -29.56%13.96M-21.77%16.42M-18.94%17.67M-17.65%18.71M174.09%19.81M177.68%20.99M174.12%21.8M197.64%22.72M-11.02%7.23M256.92%7.56M
Deferred tax assets -35.99%15.93M-26.67%17.15M-7.40%22.13M-8.52%22.79M109.44%24.89M110.01%23.39M137.13%23.9M185.35%24.91M80.25%11.88M170.94%11.14M
Usufruct assets -7.92%30.21M-8.27%30.87M-10.81%31.03M-10.10%32.59M-13.20%32.81M-9.84%33.65M-11.16%34.79M-9.28%36.25M-7.43%37.79M690.49%37.33M
Other non current assets -------------81.46%144.85K-94.47%113.45K-59.16%630.6K-85.17%301.6K-78.84%781.42K134.20%2.05M7.12%1.54M
Total non current assets -0.77%405.65M-4.55%404.06M-2.79%413.54M-1.90%417.27M-3.38%408.79M1.01%423.33M0.61%425.42M2.53%425.34M4.33%423.1M14.03%419.09M
Total assets 0.36%840.59M1.33%835.89M2.12%843.68M-1.28%859.57M-2.34%837.58M-5.99%824.95M-5.05%826.13M-3.15%870.72M-2.53%857.69M6.54%877.49M
Liabilities
Current liabilities
Short term loan 23.47%48.4M25.51%49.2M68.05%49.24M33.31%39.24M33.33%39.2M101.03%39.2M193.00%29.3M--29.43M--29.4M--19.5M
Notes payable and accounts payable -39.75%17.08M8.29%20.77M-2.63%23.67M-36.25%29.92M62.74%28.35M-4.75%19.18M43.14%24.31M69.02%46.93M-41.34%17.42M-15.74%20.13M
-Notes payable ----0.00%1M--2M-41.18%1M-75.00%1M-56.52%1M-----15.00%1.7M--4M--2.3M
-Accounts payable -37.55%17.08M8.75%19.77M-10.86%21.67M-36.06%28.92M103.80%27.35M1.93%18.18M73.85%24.31M75.55%45.23M-54.81%13.42M-25.37%17.83M
Contract liabilities 219.76%23.27M-17.15%12.83M-28.00%15.94M-47.81%16.03M-3.51%7.28M85.28%15.49M219.90%22.14M582.11%30.71M73.69%7.54M122.18%8.36M
Salaries payable 9.25%6.22M-1.98%5.79M-13.87%5.96M4.62%20.85M-10.69%5.69M-7.26%5.91M9.61%6.92M-22.74%19.93M-5.10%6.37M-14.27%6.37M
Taxs payable 5.94%5.6M138.76%5.86M27.79%7.05M51.86%10.04M-16.31%5.29M-74.14%2.46M-24.63%5.51M-22.16%6.61M-34.19%6.32M-22.25%9.5M
Other payable (including interest and dividends) -72.63%4.46M-53.51%5.93M-35.14%5.88M3.77%7.74M174.13%16.31M125.53%12.75M70.85%9.07M-21.55%7.46M10.40%5.95M-37.11%5.65M
-Other payable -----53.51%5.93M------------125.53%12.75M-----21.55%7.46M-----37.11%5.65M
Non current liabilities due within one year 0.21%5.12M-2.53%4.88M-16.62%3.84M25.22%5.52M--5.11M--5.01M--4.6M--4.41M--------
Other current liabilities 166.85%1.6M-8.42%602.9K-35.32%510.39K-66.90%545.55K-22.82%599.58K-23.10%658.3K-10.28%789.06K227.96%1.65M57.87%776.86K89.38%856.01K
Total current liabilities 3.64%111.75M5.19%105.87M9.20%112.09M-11.72%129.87M46.14%107.82M43.03%100.65M91.06%102.65M92.17%147.12M31.20%73.78M24.01%70.37M
Current liabilities
Deferred tax liabilities -79.68%50.75K-82.17%48.53K-86.13%40.67K-90.17%41.61K114.75%249.68K122.23%272.16K127.63%293.15K213.33%423.32K-17.86%116.27K-17.24%122.47K
Long term deferred income -5.47%1.73M-5.39%1.75M-5.32%1.78M-5.25%1.8M-5.18%1.83M-5.12%1.85M-5.05%1.88M-4.30%1.9M-20.41%1.93M-2.30%1.95M
Lease liabilities -7.28%29.6M-7.30%30.33M-6.93%31.36M-11.21%30.66M-22.43%31.93M-19.47%32.72M-16.81%33.69M-13.36%34.53M2.95%41.16M801.74%40.64M
Total non current liabilities -7.71%31.38M-7.78%32.14M-7.49%33.18M-11.81%32.5M-21.29%34.01M-18.41%34.85M-15.83%35.87M-12.20%36.86M1.55%43.21M541.87%42.71M
Total liabilities 0.92%143.13M1.85%138M4.88%145.27M-11.74%162.38M21.24%141.82M19.82%135.5M43.78%138.51M55.20%183.98M18.43%116.98M78.37%113.08M
Shareholders equity
Paid-in capital 0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M0.00%126.05M
Capital reserve funds 0.00%329.91M0.00%329.91M0.00%329.91M0.00%329.91M-8.74%329.91M-7.56%329.91M-6.33%329.91M-5.08%329.91M2.43%361.52M4.02%356.87M
Surplus reserve funds 4.23%43.28M4.23%43.28M4.23%43.28M4.18%43.28M0.00%41.52M0.00%41.52M0.00%41.52M0.05%41.55M13.81%41.52M13.81%41.52M
Retained profit -2.19%192.58M3.56%197.67M4.76%198.33M4.53%196.97M-7.23%196.9M-20.50%190.87M-25.32%189.32M-28.76%188.43M-19.61%212.25M-5.01%240.09M
Shareholders equity without minority interests -0.37%691.82M1.24%696.9M1.57%697.56M1.50%696.2M-6.33%694.38M-9.97%688.35M-11.18%686.8M-12.02%685.93M-4.90%741.34M0.81%764.53M
Minority interests 309.39%5.65M-10.65%986.45K4.44%852.7K21.07%992.34K317.83%1.38M1,001.83%1.1M89.95%816.46K-9.18%819.64K-137.84%-633.24K-106.46%-122.42K
Total shareholder equity 0.25%697.46M1.22%697.89M1.57%698.41M1.52%697.2M-6.07%695.76M-9.81%689.45M-11.13%687.61M-12.01%686.75M-5.18%740.71M0.55%764.41M
Total liabilityies and equity 0.36%840.59M1.33%835.89M2.12%843.68M-1.28%859.57M-2.34%837.58M-5.99%824.95M-5.05%826.13M-3.15%870.72M-2.53%857.69M6.54%877.49M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Brain science (brain-computer interface)
Brain science (brain-computer interface)
Intraday-0.69%
Medical Beauty Concept
Medical Beauty Concept
Intraday-0.76%
AI
AI
Intraday-1.07%